 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              A meeting of the Board of Directors of Bafna Pharmaceuticals Ltd will be held on June 17, 2016 to consider the proposal of issue of Equity Shares to Promoter Group and / or External Investors on a private placement / preferential allotment basis under the provisions of the Companies Act, 2013.
Further, the trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. June 10, 2016 to till the date of the Board Meeting (both days inclusive).
Shares of BAFNA PHARMACEUTICALS LTD. was last trading in BSE at Rs.28.75 as compared to the previous close of Rs. 29.1. The total number of shares traded during the day was 11489 in over 110 trades.
The stock hit an intraday high of Rs. 29.6 and intraday low of 28.75. The net turnover during the day was Rs. 335545.